Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$6.74 - $10.95 $1.49 Million - $2.42 Million
220,692 New
220,692 $1.52 Million
Q3 2020

Nov 16, 2020

SELL
$3.5 - $6.2 $432,957 - $766,952
-123,702 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $180,604 - $889,417
123,702 New
123,702 $421,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $187M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.